Shielding reduced incidence of COVID-19 in patients with inflammatory arthritis but vulnerability is associated with increased mortality | Rheumatology | Oxford Academic
Investigate whether individuals with inflammatory arthritis (IA), their treatments and shielding status affect the risk of adverse outcomes from COVID-19 for the entire population of Wales, UK. To read the full article, choose “Institutional Login” and search for “Midlands Partnership”.
